VX14-661-106: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis,

Project: Research project

Project Details

StatusFinished
Effective start/end date4/14/15 → 4/15/18

Funding

  • Vertex Pharmaceuticals Incorporated